Kim Y - Search Results

1

Reduction in hospital stay of chronic schizophrenic patients after long-term clozapine treatment.

Ahn YM, Chang JS, Kim Y, Lee KY, Kim JH, Kim SC, Maeng SJ, Kim YS. Ahn YM, et al. Among authors: kim sc, kim ys, kim y, kim jh. Int Clin Psychopharmacol. 2005 May;20(3):157-61. doi: 10.1097/00004850-200505000-00006. Int Clin Psychopharmacol. 2005. PMID: 15812266

2

A retrospective study of clozapine and electroencephalographic abnormalities in schizophrenic patients.

Chung SJ, Jeong SH, Ahn YM, Kang UG, Koo YJ, Ha JH, Lee SG, Kim YS. Chung SJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):139-44. doi: 10.1016/s0278-5846(01)00238-x. Prog Neuropsychopharmacol Biol Psychiatry. 2002. PMID: 11853104

3

Effects of MK-801 and electroconvulsive shock on c-Fos expression in the rat hippocampus and frontal cortex.

Ahn YM, Kang UG, Park JB, Kim YS. Ahn YM, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Apr;26(3):513-7. doi: 10.1016/s0278-5846(01)00299-8. Prog Neuropsychopharmacol Biol Psychiatry. 2002. PMID: 11999902

4

Region-specific phosphorylation of ATF-2, Elk-1 and c-Jun in rat hippocampus and cerebellum after electroconvulsive shock.

Ahn YM, Kang UG, Oh SW, Juhnn YS, Joo YH, Park JB, Kim YS. Ahn YM, et al. Neurosci Lett. 2002 Aug 23;329(1):9-12. doi: 10.1016/s0304-3940(02)00568-2. Neurosci Lett. 2002. PMID: 12161250

5

Subjective emotional experience and cognitive impairment in drug-induced akathisia.

Kim JH, Lee BC, Park HJ, Ahn YM, Kang UG, Kim YS. Kim JH, et al. Compr Psychiatry. 2002 Nov-Dec;43(6):456-62. doi: 10.1053/comp.2002.35908. Compr Psychiatry. 2002. PMID: 12439833

6

Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.

Kim JH, Jung HY, Kang UG, Jeong SH, Ahn YM, Byun HJ, Ha KS, Kim YS. Kim JH, et al. Mov Disord. 2002 Nov;17(6):1354-9. doi: 10.1002/mds.10255. Mov Disord. 2002. PMID: 12465082

7

Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects.

Kim JH, Yi SH, Yoo CS, Yang SA, Yoon SC, Lee KY, Ahn YM, Kang UG, Kim YS. Kim JH, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):371-8. doi: 10.1016/j.pnpbp.2003.11.007. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 14751435 Clinical Trial.

8

The effects of clozapine on the GSK-3-mediated signaling pathway.

Kang UG, Seo MS, Roh MS, Kim Y, Yoon SC, Kim YS. Kang UG, et al. Among authors: kim ys, kim y. FEBS Lett. 2004 Feb 27;560(1-3):115-9. doi: 10.1016/S0014-5793(04)00082-1. FEBS Lett. 2004. PMID: 14988008 Free article.

9

Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.

Ahn YM, Jeong SH, Jang HS, Koo YJ, Kang UG, Lee KY, Kim YS. Ahn YM, et al. Int Clin Psychopharmacol. 2004 Mar;19(2):97-101. doi: 10.1097/00004850-200403000-00007. Int Clin Psychopharmacol. 2004. PMID: 15076018

10

Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers.

Jeong SH, Joo EJ, Ahn YM, Kim YS. Jeong SH, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Sep;28(6):975-83. doi: 10.1016/j.pnpbp.2004.05.015. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 15380858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86,044 results

Search Page

Filters